 | Xenon Pharmaceuticals Inc. | |||
| NGM : XENE || Location: Canada | ||||
$41.09+1.08 (+2.7%) |
0.32 M | 39.52 - 41.59 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.756 M |
| March 15, 2024 | 2.622 M |
| Feb. 29, 2024 | 2.703 M |
| Feb. 15, 2024 | 2.526 M |
| Jan. 31, 2024 | 2.810 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.77 | -0.64 | 17.36% |
| 09/30/2023 | -0.79 | -0.73 | 7.55% |
| 06/30/2023 | -0.71 | -0.72 | -1.22% |
| 03/31/2023 | -0.63 | -0.63 | 0.63% |
| 12/31/2022 | -0.60 | -0.57 | 4.46% |
XENE Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 75.432M | Shares Float | 69.561M |
| Short Float | 2.756M | Market Cap | 3099.50M |
| Institution ownership | 99.99% | Insider ownership | 0.377% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.73 | Forward EPS | -3.29 |